- Home
- GANX vs SELF Comparison
GANX vs SELF Comparison
Compare GANX & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- SELF
- Stock Information
- Founded
- GANX 2017
- SELF 1983
- Country
- GANX United States
- SELF United States
- Employees
- GANX N/A
- SELF N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- SELF Real Estate Investment Trusts
- Sector
- GANX Health Care
- SELF Real Estate
- Exchange
- GANX Nasdaq
- SELF Nasdaq
- Market Cap
- GANX 53.8M
- SELF 56.9M
- IPO Year
- GANX 2021
- SELF N/A
- Fundamental
- Price
- GANX $1.72
- SELF $5.36
- Analyst Decision
- GANX Strong Buy
- SELF
- Analyst Count
- GANX 5
- SELF 0
- Target Price
- GANX $8.20
- SELF N/A
- AVG Volume (30 Days)
- GANX 299.5K
- SELF 29.4K
- Earning Date
- GANX 08-07-2025
- SELF 08-08-2025
- Dividend Yield
- GANX N/A
- SELF 5.44%
- EPS Growth
- GANX N/A
- SELF 15.74
- EPS
- GANX N/A
- SELF 0.22
- Revenue
- GANX N/A
- SELF $12,622,544.00
- Revenue This Year
- GANX N/A
- SELF N/A
- Revenue Next Year
- GANX N/A
- SELF N/A
- P/E Ratio
- GANX N/A
- SELF $24.24
- Revenue Growth
- GANX N/A
- SELF 3.58
- 52 Week Low
- GANX $0.89
- SELF $4.70
- 52 Week High
- GANX $3.19
- SELF $5.89
- Technical
- Relative Strength Index (RSI)
- GANX 49.29
- SELF 45.02
- Support Level
- GANX $1.55
- SELF $5.20
- Resistance Level
- GANX $1.79
- SELF $5.48
- Average True Range (ATR)
- GANX 0.16
- SELF 0.15
- MACD
- GANX -0.00
- SELF -0.01
- Stochastic Oscillator
- GANX 44.53
- SELF 42.71
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.